10-KPeriod: FY2013

TERADYNE, INC Annual Report, Year Ended Dec 31, 2013

Filed February 28, 2014For Securities:TER

Summary

Teradyne, Inc. reported consolidated net revenues of $1.43 billion for the fiscal year ended December 31, 2013, a decrease of approximately 14% from $1.66 billion in 2012. This decline was primarily driven by weaker performance in the Semiconductor Test segment, which saw a 9% revenue drop due to lower demand for application processors, and a significant 37% decrease in the System Test segment, largely attributed to reduced hard disk drive demand. The Wireless Test segment also experienced a 12% revenue decline, though this was partly offset by the recent acquisition of ZTEC Instruments Inc. The company highlighted increased investment in R&D, with expenses rising to 18.5% of revenue, reflecting a strategic focus on innovation. Despite the revenue challenges, Teradyne initiated a quarterly cash dividend program in January 2014, signaling confidence in future cash flows. The company's financial position remains solid, with a substantial cash balance and manageable debt. Investors should note the company's reliance on a few significant customers, which contributed 26% of aggregate net revenues in 2013, and the ongoing competitive pressures in its core markets. The report also disclosed the maturity of convertible senior notes in March 2014 and the potential for dilution from related warrant exercises.

Financial Statements
Beta
Revenue$1.43B
Cost of Revenue$619.13M
Gross Profit$808.80M
SG&A Expenses$279.56M
Operating Expenses$618.14M
Operating Income$190.66M
Interest Expense$26.10M
Net Income$164.95M
EPS (Basic)$0.86
EPS (Diluted)$0.70
Shares Outstanding (Basic)190.77M
Shares Outstanding (Diluted)235.60M

Key Highlights

  • 1Consolidated net revenues decreased by 14% to $1.43 billion in 2013 from $1.66 billion in 2012.
  • 2Semiconductor Test revenue declined 9% due to a softer application processor market, while System Test revenue fell 37% due to lower hard disk drive demand.
  • 3The Wireless Test segment, bolstered by the ZTEC acquisition, experienced a 12% revenue decrease.
  • 4Engineering and development expenses increased to 18.5% of revenue, indicating a commitment to innovation.
  • 5Teradyne initiated a quarterly dividend of $0.06 per share in January 2014.
  • 6The company reported a gain of $34.2 million from the sale of an equity investment in 2013.
  • 7Concentration of revenue from top customers remains a key factor, with the top three accounting for 26% of total net revenues in 2013.

Frequently Asked Questions